RT Journal Article
SR Electronic
A1 Canavan, Neil
T1 Adjuvant Gemcitabine Extends Overall Survival in Patients with Resected Pancreatic Cancer
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 4
SP 13
OP 13
DO 10.1177/155989770800800409
UL http://mdc.sagepub.com/content/8/4/13.1.abstract
AB If their disease is caught early enough, patients with pancreatic cancer may undergo a resection of the diseased organ; this procedure, though intended to be curative, most often results in only a modest increase in overall survival. This article discusses adjuvant treatment with gemcitabine for patients with pancreatic cancer.